Concepedia

A phase II randomized trial of docetaxel weekly or every 3 weeks in elderly and/or poor performance status (PS) patients (pts) with advanced non-small cell lung cancer (NSCLC)

Rogério Lilenbaum, Mark A. Rubin, Joyce P. Samuel, László G. Boros, Tarek Chidiac, L. Seigel, Patricia Graham

Journal of Clinical Oncology · 2004 · 25 citations · 0 references

Concepts

PharmacyOncologyPharmacotherapyChemotherapyGeriatric PharmacotherapyOncology PharmacotherapyChemotherapy Toxicity In Older AdultsChemotherapy Toxicity ManagementDose SchedulingLung Cancer PharmacotherapyToxicity ManagementGeriatric Chemotherapy ToxicityHematologic Toxicity AssessmentNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer TreatmentPhase Ii InvestigationWeekly Scheduling

Abstract

7057